Acasti Pharma Inc. sell PlusUltra
Start price
10.01.21
/
50%
€24.00
Target price
10.01.22
-
Performance (%)
-68.75%
End price
11.01.22
€7.50
Summary
This prediction ended on 11.01.22 with a price of €7.50. PlusUltra correctly predicted massive losses of -68.75% for Acasti Pharma Inc.. PlusUltra has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Acasti Pharma Inc. | 0.840% | 0.840% | 2.801% | -87.450% |
iShares Core DAX® | -0.205% | 2.528% | 16.157% | 18.725% |
iShares Nasdaq 100 | 1.613% | 4.733% | 30.626% | 56.133% |
iShares Nikkei 225® | -0.740% | 0.396% | 9.039% | 5.948% |
iShares S&P 500 | 0.267% | 2.720% | 26.333% | 47.720% |
Comments by PlusUltra for this prediction
In the thread Discuss Acasti Pharma Inc
Sell Acasti Pharma Inc
In the thread Trading Acasti Pharma Inc
Die von PlusUltra gewählte maximale Laufzeit wurde überschritten